Access
This article is part of Nature's premium content.
Published online 23 July 2004 | Nature | doi:10.1038/news040719-16
News
First 'black' drug nears approval
Controversial study suggests treatment should factor in the patient’s ethnic group.
A heart drug being tested in black patients is on course to become the first medicine approved for use in a specific ethnic group, challenging those scientists who believe that race is a bad basis for prescriptions.
The drug, made by Massachusetts-based pharmaceutical company NitroMed, was abandoned after a trial in the 1980s produced unimpressive results.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
